20 May 2010
Iliac artery in-stent restenosis evaluation in 64-row CT
Wojciech Poncyljusz, Aleksander Falkowski, Marcin Sawicki, Monika Rać, Robert JuszkatMed Sci Monit 2010; 16(1): 43-47 :: ID: 880582
Abstract
Background: The aim of our study was to assess the sensitivity and accuracy of computed tomography angiography (CTA) for the detection of variable degrees of iliac artery in-stent restenosis compared with digital subtraction angiography (DSA).
Material/Methods: Twenty patients (39 women, 43%; 51 men, 57%) with suspected iliac in-stent restenosis were prospectively evaluated with CTA using a 64-row multidetector CT scanner and DSA examination. The patients’ mean age was 63 ±6 years (range, 56 to 81 years). DSA and CTA studies were performed during one hospital stay. Ninety uncovered implanted commercially available stents were suspected of in-stent restenosis: 14 stainless-steel Express Vascular LD, 26 Wallstent, and 50 nitinol Smart stents. Restenosis in the stented segments were divided into four categories: A – minimal intimal hyperplasia in the stented segment <30%; B – hyperplasia obstructing <50% of the lumen diameter in the stented segment; C – hyperplasia obstructing <99% of the lumen diameter in the stented segment; and D – occluding the intimal hyperplasia in the stented segment.
Result: It was possible to visualize the stent diameter, lumen, and degree of in-stent restenosis. Comparisons between CTA and DSA in-stent restenosis in the B, C, and D groups were identical (sensitivity and specificity were 100%). In group A, the sensitivity was 100%, but the specificity was only 80%.
Conclusions: This study demonstrated that 64-row multidetector CTA is a sensitive and accurate noninvasive vascular imaging investigation to detect in-stent restenosis in iliac arteries. Final evaluation needs routine postprocessing analysis. CTA allows radiologists and surgeon to plan corrective endovascular procedures.
Keywords: Iliac Artery, in-stent restenosis, multidetector-CT-angiography, DSA
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952